Citation: B. Paszner et al., Neutralising antibodies to interferon-beta in the treatment of multiple sclerosis - Cause for concern?, CNS DRUGS, 11(3), 1999, pp. 225-243
Citation: Ks. Cover et al., Lesion load reproducibility and statistical sensitivity of clinical trialsin multiple sclerosis, NEUROLOGY, 52(2), 1999, pp. 433-434
Authors:
Cutter, GR
Baier, ML
Rudick, RA
Cookfair, DL
Fischer, JS
Petkau, J
Syndulko, K
Weinshenker, BG
Antel, JP
Confavreux, C
Ellison, GW
Lublin, F
Miller, AE
Rao, SM
Reingold, S
Thompson, A
Willoughby, E
Citation: Gr. Cutter et al., Development of a multiple sclerosis functional composite as a clinical trial outcome measure, BRAIN, 122, 1999, pp. 871-882